| Literature DB >> 26510691 |
David J Diller1, Jon Swanson2, Alexander S Bayden1, Mark Jarosinski1, Joseph Audie1,3.
Abstract
Peptides provide promising templates for developing drugs to occupy a middle space between small molecules and antibodies and for targeting 'undruggable' intracellular protein-protein interactions. Importantly, rational or in cerebro design, especially when coupled with validated in silico tools, can be used to efficiently explore chemical space and identify islands of 'drug-like' peptides to satisfy diverse drug discovery program objectives. Here, we consider the underlying principles of and recent advances in rational, computer-enabled peptide drug design. In particular, we consider the impact of basic physicochemical properties, potency and ADME/Tox opportunities and challenges, and recently developed computational tools for enabling rational peptide drug design. Key principles and practices are spotlighted by recent case studies. We close with a hypothetical future case study.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26510691 DOI: 10.4155/fmc.15.142
Source DB: PubMed Journal: Future Med Chem ISSN: 1756-8919 Impact factor: 3.808